Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease (ADMIRE-CD)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01541579 |
Recruitment Status :
Completed
First Posted : March 1, 2012
Last Update Posted : November 29, 2019
|
Sponsor:
Tigenix S.A.U.
Information provided by (Responsible Party):
Takeda ( Tigenix S.A.U. )
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | July 2015 |
Actual Study Completion Date : | November 2016 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):